160 related articles for article (PubMed ID: 32454856)
21. Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis.
Dong S; Chen QL; Su SB
Evid Based Complement Alternat Med; 2015; 2015():125659. PubMed ID: 26221168
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant Fuzheng Huayu Capsule Reduces the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-Caused Cirrhosis.
Shi K; Liu Y; Wang X; Li Y; Zhang Q; Hu Y; Ran C; Huang Y; Hou J; Wang X
Evid Based Complement Alternat Med; 2020; 2020():8826091. PubMed ID: 33178324
[TBL] [Abstract][Full Text] [Related]
23. Fuzheng Huayu capsule as an adjuvant treatment for HBV-related cirrhosis: A systematic review and meta-analysis.
Wang T; Zhou X; Liu H; Wang J; Zhang P; Zhu Y; Li K; Wei S; Li H; Wang L; Wang R; Zhao Y
Phytother Res; 2018 May; 32(5):757-768. PubMed ID: 29235181
[TBL] [Abstract][Full Text] [Related]
24. Effect of Fuzheng Huayu capsule combined with Pegasys on genotype 1 hepatitis C fibrosis and cell apoptosis.
Zhang B; Hu M; Huang L; Pu Y; Pei H; Hua Z; Yao S
Exp Ther Med; 2014 Oct; 8(4):1123-1126. PubMed ID: 25187808
[TBL] [Abstract][Full Text] [Related]
25. Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis.
Wu R; Dong S; Cai FF; Chen XL; Yang MD; Liu P; Su SB
Molecules; 2019 Jan; 24(2):. PubMed ID: 30669350
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological mechanisms of Fuzheng Huayu formula for Aristolochic acid I-induced kidney fibrosis through network pharmacology.
Wang F; Wang S; Wang J; Huang K; Chen G; Peng Y; Liu C; Tao Y
Front Pharmacol; 2022; 13():1056865. PubMed ID: 36569327
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial.
Hassanein T; Tai D; Liu C; Box TD; Tong MJ; Rossaro L; Pozza R; Glenn JS; Cheung R; Hemaidan A; He Y; Behling C; Hu X; Makhlouf H; Fan H; Ren Y; Khim Chng EL; Liu P; Vierling JM
Evid Based Complement Alternat Med; 2022; 2022():4494099. PubMed ID: 35873630
[TBL] [Abstract][Full Text] [Related]
28. [Action mechanism and active components of Fuzheng Huayu Recipe against liver fibrosis via regulating macrophage with network pharmacology and transcriptomics methods].
Xing L; Hu XD; Tao YY; Peng Y; Liu CH
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(11):3029-3037. PubMed ID: 35718527
[TBL] [Abstract][Full Text] [Related]
29. Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats.
Xie H; Tao Y; Lv J; Liu P; Liu C
Evid Based Complement Alternat Med; 2013; 2013():972863. PubMed ID: 23431353
[TBL] [Abstract][Full Text] [Related]
30. Effect of Fuzheng Huayu formula and its actions against liver fibrosis.
Liu C; Hu Y; Xu L; Liu C; Liu P
Chin Med; 2009 Jun; 4():12. PubMed ID: 19558726
[TBL] [Abstract][Full Text] [Related]
31. [Study on anti- fibrotic mechanism of Fuzheng -Huayu formula to suppress autophagy in mice].
Huang LW; Jiang N; Ping J; Zhang J; Xu LM
Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):621-627. PubMed ID: 31594080
[No Abstract] [Full Text] [Related]
32. Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis.
Muhanna N; Doron S; Wald O; Horani A; Eid A; Pappo O; Friedman SL; Safadi R
Hepatology; 2008 Sep; 48(3):963-77. PubMed ID: 18726940
[TBL] [Abstract][Full Text] [Related]
33. Syndrome of liver depression and spleen deficiency is a primary TCM syndrome of response to entecavir + FuZheng HuaYu in patients with HBV-related liver fibrosis.
Dai YK; Fan HN; Zhao ZM; Shen L; Liu CH
Heliyon; 2023 Nov; 9(11):e22216. PubMed ID: 38045133
[TBL] [Abstract][Full Text] [Related]
34. Chinese herbal formula Fuzheng Huayu alleviates CCl
Dong S; Cai FF; Chen QL; Song YN; Sun Y; Wei B; Li XY; Hu YY; Liu P; Su SB
Acta Pharmacol Sin; 2018 Jun; 39(6):930-941. PubMed ID: 29094729
[TBL] [Abstract][Full Text] [Related]
35. Metabolic mechanisms of Fuzheng-Huayu formula against liver fibrosis in rats.
Hu XQ; Song YN; Wu R; Cai FF; Zhang Y; Peng JH; Hu YY; Su SB
J Ethnopharmacol; 2019 Jun; 238():111888. PubMed ID: 31004725
[TBL] [Abstract][Full Text] [Related]
36. [Clinical study of yiqi huoxue recipe in the treatment of liver fibrosis of chronic viral hepatitis].
Cui LY; Zhang XX; Cui P; Li WC; Zhang YG; Wang RQ; Zhao SX; Ren WG; Kong LL; Han F; Yuan XW; Liu LD; Zhang Y; Zhang QS; Kong L; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2020 May; 28(5):403-409. PubMed ID: 32536056
[No Abstract] [Full Text] [Related]
37. Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells.
Pan Q; Wang YQ; Li GM; Duan XY; Fan JG
Biomed Res Int; 2015; 2015():935903. PubMed ID: 26881209
[TBL] [Abstract][Full Text] [Related]
38. Comparative pharmacokinetics and tissue distribution profiles of lignan components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe.
Yang T; Liu S; Zheng TH; Tao YY; Liu CH
J Ethnopharmacol; 2015 May; 166():305-12. PubMed ID: 25794805
[TBL] [Abstract][Full Text] [Related]
39. Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis.
Gui HL; Zhao CQ; Wang Y; Gu HT; Wang WJ; Cai W; Guo Q; Bao SS; Xu LM; Xie Q
J Clin Transl Hepatol; 2020 Sep; 8(3):277-284. PubMed ID: 33083250
[No Abstract] [Full Text] [Related]
40. Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in rats.
Tian H; Liu L; Li Z; Liu W; Sun Z; Xu Y; Wang S; Liang C; Hai Y; Feng Q; Zhao Y; Hu Y; Peng J
J Ethnopharmacol; 2019 Mar; 232():227-235. PubMed ID: 30471378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
